Amrinone, isoproterenol and ouabain modification of cardiac K+ contracture

Marion S. Gaide, Stephen P. Baker, Alan M. Ezrin, Henry Gelband, Arthur L. Bassett

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The effects of amrinone, a new cardiotonic bipyridine derivative, were compared to those isoproterenol and ouabain on maintained K+-induced contracture of isolated cat ventricualr muscle. Peak K+induced contracture force was decreased by amrinone (5.3 × 10-4 M) and isoproterenol (10-6 M), 31 ± 10% (n = 4, P ≤ 0.05) and 81 ± 5% (n = 4, P ≤ 0.05), respectively, and increased by ouabain (5.0 x 10-7 M), 60 ± 6% (n = 4, P ≤ 0.05). The effects of amrinone and ouabain on K+ contracture persisted during β-adrenergic blockade produced by nadolol (10- M) whereas isoproterenol's actions were attenuated. The effect of amrinone on K+-contracture force was concentration-related as was its modification of phasic isometric contractions (0.5 Hz). Resting tension, time to peak force and durection of isometric contraction were unchanged by amirone (5.3 × 10-6-1.6 × 10-3 M). Apparently, amrinone concomitantly Ca2+ release and sequestration or extrusion and thus the drug may not provoke cardiac toxicity by Ca2+ overload.

Original languageEnglish
Pages (from-to)253-260
Number of pages8
JournalEuropean Journal of Pharmacology
Volume73
Issue number4
DOIs
StatePublished - Aug 14 1981
Externally publishedYes

Fingerprint

Amrinone
Contracture
Ouabain
Isoproterenol
Isometric Contraction
Nadolol
Cardiotonic Agents
Adrenergic Agents
Cats
Muscles
Pharmaceutical Preparations

Keywords

  • Ca release
  • Isolated cat ventricular muscle
  • Isometric force Sequestration or extrusion
  • Nadolol
  • β-Receptor blockade

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Gaide, M. S., Baker, S. P., Ezrin, A. M., Gelband, H., & Bassett, A. L. (1981). Amrinone, isoproterenol and ouabain modification of cardiac K+ contracture. European Journal of Pharmacology, 73(4), 253-260. https://doi.org/10.1016/0014-2999(81)90225-9

Amrinone, isoproterenol and ouabain modification of cardiac K+ contracture. / Gaide, Marion S.; Baker, Stephen P.; Ezrin, Alan M.; Gelband, Henry; Bassett, Arthur L.

In: European Journal of Pharmacology, Vol. 73, No. 4, 14.08.1981, p. 253-260.

Research output: Contribution to journalArticle

Gaide, Marion S. ; Baker, Stephen P. ; Ezrin, Alan M. ; Gelband, Henry ; Bassett, Arthur L. / Amrinone, isoproterenol and ouabain modification of cardiac K+ contracture. In: European Journal of Pharmacology. 1981 ; Vol. 73, No. 4. pp. 253-260.
@article{f254fde00a1c4ec39624592f4978c606,
title = "Amrinone, isoproterenol and ouabain modification of cardiac K+ contracture",
abstract = "The effects of amrinone, a new cardiotonic bipyridine derivative, were compared to those isoproterenol and ouabain on maintained K+-induced contracture of isolated cat ventricualr muscle. Peak K+induced contracture force was decreased by amrinone (5.3 × 10-4 M) and isoproterenol (10-6 M), 31 ± 10{\%} (n = 4, P ≤ 0.05) and 81 ± 5{\%} (n = 4, P ≤ 0.05), respectively, and increased by ouabain (5.0 x 10-7 M), 60 ± 6{\%} (n = 4, P ≤ 0.05). The effects of amrinone and ouabain on K+ contracture persisted during β-adrenergic blockade produced by nadolol (10- M) whereas isoproterenol's actions were attenuated. The effect of amrinone on K+-contracture force was concentration-related as was its modification of phasic isometric contractions (0.5 Hz). Resting tension, time to peak force and durection of isometric contraction were unchanged by amirone (5.3 × 10-6-1.6 × 10-3 M). Apparently, amrinone concomitantly Ca2+ release and sequestration or extrusion and thus the drug may not provoke cardiac toxicity by Ca2+ overload.",
keywords = "Ca release, Isolated cat ventricular muscle, Isometric force Sequestration or extrusion, Nadolol, β-Receptor blockade",
author = "Gaide, {Marion S.} and Baker, {Stephen P.} and Ezrin, {Alan M.} and Henry Gelband and Bassett, {Arthur L.}",
year = "1981",
month = "8",
day = "14",
doi = "10.1016/0014-2999(81)90225-9",
language = "English",
volume = "73",
pages = "253--260",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Amrinone, isoproterenol and ouabain modification of cardiac K+ contracture

AU - Gaide, Marion S.

AU - Baker, Stephen P.

AU - Ezrin, Alan M.

AU - Gelband, Henry

AU - Bassett, Arthur L.

PY - 1981/8/14

Y1 - 1981/8/14

N2 - The effects of amrinone, a new cardiotonic bipyridine derivative, were compared to those isoproterenol and ouabain on maintained K+-induced contracture of isolated cat ventricualr muscle. Peak K+induced contracture force was decreased by amrinone (5.3 × 10-4 M) and isoproterenol (10-6 M), 31 ± 10% (n = 4, P ≤ 0.05) and 81 ± 5% (n = 4, P ≤ 0.05), respectively, and increased by ouabain (5.0 x 10-7 M), 60 ± 6% (n = 4, P ≤ 0.05). The effects of amrinone and ouabain on K+ contracture persisted during β-adrenergic blockade produced by nadolol (10- M) whereas isoproterenol's actions were attenuated. The effect of amrinone on K+-contracture force was concentration-related as was its modification of phasic isometric contractions (0.5 Hz). Resting tension, time to peak force and durection of isometric contraction were unchanged by amirone (5.3 × 10-6-1.6 × 10-3 M). Apparently, amrinone concomitantly Ca2+ release and sequestration or extrusion and thus the drug may not provoke cardiac toxicity by Ca2+ overload.

AB - The effects of amrinone, a new cardiotonic bipyridine derivative, were compared to those isoproterenol and ouabain on maintained K+-induced contracture of isolated cat ventricualr muscle. Peak K+induced contracture force was decreased by amrinone (5.3 × 10-4 M) and isoproterenol (10-6 M), 31 ± 10% (n = 4, P ≤ 0.05) and 81 ± 5% (n = 4, P ≤ 0.05), respectively, and increased by ouabain (5.0 x 10-7 M), 60 ± 6% (n = 4, P ≤ 0.05). The effects of amrinone and ouabain on K+ contracture persisted during β-adrenergic blockade produced by nadolol (10- M) whereas isoproterenol's actions were attenuated. The effect of amrinone on K+-contracture force was concentration-related as was its modification of phasic isometric contractions (0.5 Hz). Resting tension, time to peak force and durection of isometric contraction were unchanged by amirone (5.3 × 10-6-1.6 × 10-3 M). Apparently, amrinone concomitantly Ca2+ release and sequestration or extrusion and thus the drug may not provoke cardiac toxicity by Ca2+ overload.

KW - Ca release

KW - Isolated cat ventricular muscle

KW - Isometric force Sequestration or extrusion

KW - Nadolol

KW - β-Receptor blockade

UR - http://www.scopus.com/inward/record.url?scp=0019409220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019409220&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(81)90225-9

DO - 10.1016/0014-2999(81)90225-9

M3 - Article

AN - SCOPUS:0019409220

VL - 73

SP - 253

EP - 260

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 4

ER -